559
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Cognition in the course of ALS—a meta-analysis

, , , &
Pages 2-13 | Received 26 Jan 2022, Accepted 11 Jul 2022, Published online: 22 Jul 2022

References

  • Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
  • Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
  • Beeldman E, Raaphorst J, Twennaar MK, Visser MD, Schmand BA, Haan RD. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87:611–9.
  • Benbrika S, Desgranges B, Eustache F, Viader F. Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review. Front Neurosci 2019;13:951.
  • De Marchi F, Carrarini C, De Martino A, Diamanti L, Fasano A, Lupica A, et al. Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? Neurol Sci. 2021;42:2211–22.
  • Papma JM, Jiskoot LC, Panman JL, Dopper EG, Heijer T d, Kaat LD, et al. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology 2017;89:1256–64.
  • Lulé DE, Müller HP, Finsel J, Weydt P, Knehr A, Winroth I, et al. Deficits in verbal fluency in presymptomatic C9orf72 mutation gene carriers—a developmental disorder. J Neurol Neurosurg Psychiatry. 2020;91:1195–200.
  • Raaphorst J, de Visser M, Linssen W, de Haan R, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2010;11:27–37.
  • Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83:102–8.
  • Yang T, Hou Y, Li C, Cao B, Cheng Y, Wei Q, et al. Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2021;92:688–93.
  • Rock P, Roiser J, Riedel W, Blackwell A, Rock PL, Roiser JP, Riedel WJ, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44:2029–40.
  • Lulé D, Häcker S, Ludolph A, Birbaumer N, Kübler A. Depression und Lebensqualität bei Patienten mit Amyotropher Lateral Sklerose. Dtsch Ärztebl. 2008;105:825.
  • Roos E, Mariosa D, Ingre C, Lundholm C, Wirdefeldt K, Roos PM, et al. Depression in amyotrophic lateral sclerosis. Neurology 2016;86:2271–7.
  • Lulé D, Pauli S, Altintas E, Singer U, Merk T, Uttner I, et al. Emotional adjustment in amyotrophic lateral sclerosis (ALS). J Neurol. 2012;259:334–41.
  • Vázquez Medrano CR, Aho-Özhan HEA, Weiland U, Uttner I, Ludolph AC, Lulé D. Disease progression but not physical state per se determines mental wellbeing in ALS. J Neurol. 2020;267:3593–601.
  • Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–90.
  • Rabkin J, Goetz R, Murphy JM, Factor-Litvak P, Mitsumoto H, ALS COSMOS Study Group. Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort. Neurology 2016;87:1320–8.
  • Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291–2.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
  • Wells G, Shea B, O’Connell D, Robertson J, Peterson J, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-analysis. 2000. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed April 25, 2016.
  • Harvey PD. Domains of cognition and their assessment. Dialogues Clin Neurosci. 2019;21:227–37.
  • Shao Z, Janse E, Visser K, Meyer AS. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front Psychol 2014;5:772.
  • Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Soft. 2010;36:1–48.
  • Harrer M, Cuijpers P, Furukawa T, Ebert D. Doing meta-analysis in R: a hands-on guide. London, UK: CRC Press/Chapman & Hall; 2019.
  • Brooks BR. The ALS Norris score: insight into the natural history provided by Forbes Norris. In: Rose FC, ed. The Forbes H Norris Memorial Volume ALS: from Charcot to the present and into the future. London: Smith-Gordon; 1994.
  • Proudfoot M, Menke RAL, Sharma R, Berna CM, Hicks SL, Kennard C, et al. Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:101–11.[
  • Poletti B, Solca F, Carelli L, Faini A, Madotto F, Lafronza A, et al. Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:387–95.
  • Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Lomen-Hoerth C, et al. Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behav Neurol. 2018;2018:e5969137.
  • Trojsi F, Nardo FD, Siciliano M, Caiazzo G, Femiano C, Passaniti C, et al. Frontotemporal degeneration in amyotrophic lateral sclerosis (ALS): a longitudinal MRI one-year study. CNS Spectr. 2021;26:258–67.
  • van der Burgh HK, Westeneng HJ, Walhout R, van Veenhuijzen K, Tan HHG, Meier JM, et al. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology 2020;94:e2592–604.
  • Gillingham SM, Yunusova Y, Ganda A, Rogaeva E, Black SE, Stuss DT, et al. Assessing cognitive functioning in ALS: a focus on frontal lobe processes. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:182–92.
  • Burkhardt C, Neuwirth C, Weber M. Longitudinal assessment of the Edinburgh cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS): lack of practice effect in ALS patients? Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:202–9.
  • Libon D, Glosser G, Malamut B, Kaplan E, Goldberg E, Swenson R, et al. Age, executive functions, and visuospatial functioning in healthy older adults. Neuropsychology 1994;8:38–43.
  • Lehrner J, Krakhofer H, Lamm C, Macher S, Moser D, Klug S, et al. Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer’s disease, and Parkinson’s disease. Neuropsychiatr. 2015;29:112–9.
  • Murman DL. The impact of age on cognition. Semin Hear. 2015;36:111–21.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). USA: American Psychiatric Pub; 2013:1414.
  • Matuz T, Birbaumer N, Hautzinger M, Kubler A. Coping with amyotrophic lateral sclerosis: an integrative view. J Neurol Neurosurg Psychiatry. 2010;81:893–8.
  • Gaur N, Prell T, Grosskreutz J, Witte O, Stubendorff B, Rödiger A. Disease progression impacts health-related quality of life in amyotrophic lateral sclerosis. J Neurol Sci. 2019;397:92–5.
  • Schreiber H, Gaigalat T, Wiedemuth-Catrinescu U, Graf M, Uttner I, Muche R, et al. Cognitive function in bulbar– and spinal–onset amyotrophic lateral sclerosis. J Neurol. 2005;252:772–81.
  • Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology 1999;53:1665.
  • Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, McCluskey LF. Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study. J Neurol Neurosurg Psychiatry. 2006;77:668–70.
  • Beeldman E, Govaarts R, de Visser M, Twennaar MK, van der Kooi AJ, van den Berg LH, et al. Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2020;91:779–80.
  • Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, Wynne B, et al. Cognitive changes predict functional decline in ALS: a population-based longitudinal study. Neurology 2013;80:1590–7.
  • Floeter MK, Traynor BJ, Farren J, Braun LE, Tierney M, Wiggs EA, et al. Disease progression in C9orf72 mutation carriers. Neurology 2017;89:234–41.
  • Costello E, Rooney J, Pinto-Grau M, Burke T, Elamin M, Bede P, et al. Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study. J Neurol Neurosurg Psychiatry. 2021;92:460–5.
  • Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
  • Pender N, Pinto-Grau M, Hardiman O. Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:649–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.